Haemoglobin as a marker of fibrosis in early diabetic kidney disease

Nephrol Dial Transplant. 2022 Feb 25;37(3):403-404. doi: 10.1093/ndt/gfab217.

Authors

Anna Faivre¹, Sophie de Seigneux¹

Affiliation

¹ Service and Laboratory of Nephrology, Department of Medicine and Cell Physiology and Metabolism, University Hospital of Geneva, Geneva, Switzerland.

PMID: 34383946
DOI: 10.1093/ndt/gfab217

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Diabetes Mellitus*
Diabetic Nephropathies* / diagnosis
Diabetic Nephropathies* / etiology
Diabetic Nephropathies* / physiopathology
Fibrosis
Hemoglobin, Sickle
Hemoglobins
Humans

Substances

Biomarkers
Hemoglobin, Sickle
Hemoglobins
hemoglobin AS